IDEXX Laboratories Inc
NASDAQ:IDXX
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
406.92
576.87
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one IDXX stock under the Base Case scenario is 254.3 USD. Compared to the current market price of 414.52 USD, IDEXX Laboratories Inc is Overvalued by 39%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
IDEXX Laboratories Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for IDXX cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
IDEXX Laboratories Inc. is a leading global provider of veterinary diagnostic products and services, dedicated to enhancing the health and well-being of pets worldwide. Founded in 1983, the company has established itself as an innovator in the animal healthcare market, offering a comprehensive range of diagnostic tests, equipment, and software that empower veterinarians to make informed decisions. With a consistent focus on research and development, IDEXX has expanded its portfolio to include cutting-edge solutions such as digital imaging and telemedicine, addressing the growing needs of the pet care industry. Their strategic partnerships and robust distribution channels further bolster thei...
IDEXX Laboratories Inc. is a leading global provider of veterinary diagnostic products and services, dedicated to enhancing the health and well-being of pets worldwide. Founded in 1983, the company has established itself as an innovator in the animal healthcare market, offering a comprehensive range of diagnostic tests, equipment, and software that empower veterinarians to make informed decisions. With a consistent focus on research and development, IDEXX has expanded its portfolio to include cutting-edge solutions such as digital imaging and telemedicine, addressing the growing needs of the pet care industry. Their strategic partnerships and robust distribution channels further bolster their presence in both developed and emerging markets.
For investors, IDEXX represents a compelling opportunity within a steadily growing sector. The company's recurring revenue model, driven by its suite of diagnostic tests and subscriptions to software solutions, ensures stable cash flow and predictability in earnings. IDEXX has also demonstrated impressive financial performance, characterized by strong revenue growth, high profit margins, and a commitment to shareholder returns. By harnessing trends in pet ownership and increasing expenditures on pet healthcare, IDEXX positions itself as a reliable player in the marketplace. With its dedication to innovation, customer service, and global expansion, IDEXX Laboratories Inc. stands poised for sustained growth, making it an attractive consideration for long-term investors.
IDEXX Laboratories, Inc. is a leading global company that provides diagnostic and information technology solutions for animal health, water testing, and dairy markets. The core business segments of IDEXX can be categorized into the following:
-
Animal Health:
- Diagnostic Products and Services: This segment is the largest, providing a range of veterinary diagnostic test kits, laboratory services, and software solutions. Products include in-clinic diagnostic tests and point-of-care instruments (such as the IDEXX Catalyst and Snap tests) that help veterinarians diagnose and monitor animal health.
- Veterinary Software and Services: IDEXX also offers practice management software solutions, including IDEXX Neo, which helps veterinary practices manage their operations more efficiently.
-
Water Quality Testing:
- IDEXX provides testing products and services for water quality, focusing on ensuring the safety of drinking water and recreational waters. This includes kits and assays that test for contaminants like E. coli and other pathogens.
-
Dairy and Milk Quality:
- This segment offers testing solutions for dairy farms, including milk quality tests and services that help ensure dairy products meet health and safety standards. IDEXX’s products support dairy producers in managing herd health and optimizing milk production.
-
Livestock and Poultry:
- IDEXX also provides diagnostics and health monitoring solutions for livestock and poultry, which help farmers and producers to monitor animal health, reduce disease outbreaks, and enhance food safety.
These segments collectively contribute to IDEXX’s mission of improving the health and well-being of animals and humans through innovative diagnostic tools and technologies. The company's emphasis on research and development allows it to continuously enhance its product offerings across these business segments.
IDEXX Laboratories Inc. is a leading global provider of diagnostic products and services for the veterinary, livestock, and poultry industries. The company's competitive advantages can be attributed to several factors:
-
Innovative Product Portfolio: IDEXX offers a wide range of advanced diagnostic tests and technologies, including point-of-care tests and diagnostic imaging systems. Their commitment to research and development has led to continuous innovation, keeping them ahead of competitors.
-
Strong Brand Reputation: IDEXX is well-established in the veterinary diagnostics market, known for high-quality products and reliability. This brand recognition fosters customer loyalty and trust.
-
Comprehensive Relationship with Veterinarians: IDEXX has developed strong relationships with veterinarians by providing not only diagnostic products but also educational resources and support services. This holistic approach allows them to maintain a loyal customer base.
-
Distribution and Market Access: IDEXX has an extensive global distribution network, which enables them to efficiently reach customers in various markets. This broad access helps them to scale operations and capitalize on emerging market opportunities.
-
Data-Driven Insights: With their focus on diagnostic testing, IDEXX is able to gather extensive data on animal health, allowing for better disease management and decision-making. This not only improves outcomes for pets and livestock but also helps solidify IDEXX's position as a thought leader in veterinary health.
-
Economies of Scale: As one of the largest players in the veterinary diagnostics market, IDEXX benefits from economies of scale that allow them to lower production costs and invest more in research and development compared to smaller competitors.
-
Focus on Customer Support and Services: IDEXX places a strong emphasis on customer service and support, ensuring that veterinarians have access to training, technical support, and other resources that enhance their product utility.
-
Diversified Revenue Streams: The company derives revenue from various segments, including companion animals, livestock and poultry, and water testing. This diversification helps mitigate risks associated with market fluctuations in any one segment.
-
Commitment to Sustainability: IDEXX's focus on sustainable practices can resonate well with customers increasingly concerned about environmental issues, thus providing additional appeal over competitors that may not prioritize these initiatives.
-
Strong Financial Performance: IDEXX's robust financial performance, characterized by consistent revenue growth and profitability, allows the company to reinvest in innovation and strategic initiatives to further enhance their market position.
In summary, IDEXX Laboratories enjoys distinctive competitive advantages through its innovative product offerings, strong relationships with veterinarians, broad market access, and a commitment to ongoing improvement and sustainability. These factors collectively help the company maintain a leading position in the veterinary diagnostics industry.
IDEXX Laboratories Inc., a leader in veterinary diagnostics, water testing, and livestock and poultry health, faces several risks and challenges in the near future:
-
Market Competition: The veterinary diagnostics market is highly competitive, with both established players and new entrants. Competitors may offer innovative products or lower pricing, which could impact IDEXX's market share.
-
Regulatory Changes: The company operates in a heavily regulated industry. Changes in regulations related to veterinary practices, animal health, and diagnostics can pose significant challenges, including compliance costs and potential penalties.
-
Economic Factors: Economic downturns or changes in consumer spending behavior can affect the demand for veterinary services. Pet owners may delay or forgo spending on diagnostic tests during economic hardships.
-
Technological Advancements: Rapid advancements in technology necessitate continuous innovation. IDEXX must invest in research and development to keep pace with new technologies and to meet evolving customer needs.
-
Cybersecurity Threats: As a technology-driven company, IDEXX faces risks related to data breaches and cyberattacks. Protecting sensitive customer and patient information is critical.
-
Supply Chain Disruptions: Global events, such as pandemics or geopolitical tensions, can disrupt supply chains, affecting the availability of materials or products necessary for IDEXX's operations.
-
Global Market Risks: Expansion into international markets can introduce risks related to currency fluctuations, political instability, and varying regulatory environments.
-
Customer Retention: Maintaining strong relationships with veterinarians and clinics is vital. If IDEXX fails to provide satisfactory products or services, it risks losing customers to competitors.
-
Labor Market Challenges: Difficulty in hiring and retaining skilled labor, particularly in research and technical roles, can hamper IDEXX’s operations and innovation.
-
Health Trends and Changes in Pet Ownership: Changes in pet ownership trends, such as decreased pet adoption or shifts in consumer attitudes toward pet care, can affect demand for IDEXX’s products and services.
Overall, while IDEXX Laboratories has a strong market position, these risks necessitate strategic planning, ongoing innovation, and robust risk management to sustain growth and adaptability in a changing environment.
Revenue & Expenses Breakdown
IDEXX Laboratories Inc
Balance Sheet Decomposition
IDEXX Laboratories Inc
Current Assets | 1.4B |
Cash & Short-Term Investments | 308.6m |
Receivables | 511.3m |
Other Current Assets | 613.9m |
Non-Current Assets | 1.9B |
PP&E | 717.7m |
Other Non-Current Assets | 1.2B |
Current Liabilities | 1B |
Accounts Payable | 110.6m |
Accrued Liabilities | 511m |
Short-Term Debt | 250m |
Other Current Liabilities | 137.6m |
Non-Current Liabilities | 723.5m |
Long-Term Debt | 524.8m |
Other Non-Current Liabilities | 198.7m |
Earnings Waterfall
IDEXX Laboratories Inc
Revenue
|
3.8B
USD
|
Cost of Revenue
|
-1.5B
USD
|
Gross Profit
|
2.3B
USD
|
Operating Expenses
|
-1.2B
USD
|
Operating Income
|
1.1B
USD
|
Other Expenses
|
-245.7m
USD
|
Net Income
|
866.2m
USD
|
Free Cash Flow Analysis
IDEXX Laboratories Inc
USD | |
Free Cash Flow | USD |
In Q3 2024, IDEXX Laboratories experienced a 6% organic revenue increase, with a notable 13% growth in its water business. Although the CAG Diagnostics segment showed organic growth of 7%, overall growth was moderated by U.S. macroeconomic pressures, leading to an updated organic growth guidance of 5.3% to 6% for the full year. The EPS rose to $2.80, marking an 11% increase. Looking forward, IDEXX expects Q4 revenue growth of approximately 3% and CAG Diagnostic recurring revenue growth of 3.5% to 4%. Their innovative product, the inVue Dx Analyzer, has garnered nearly 700 pre-orders, signaling strong future demand.
What is Earnings Call?
IDXX Profitability Score
Profitability Due Diligence
IDEXX Laboratories Inc's profitability score is 74/100. The higher the profitability score, the more profitable the company is.
Score
IDEXX Laboratories Inc's profitability score is 74/100. The higher the profitability score, the more profitable the company is.
IDXX Solvency Score
Solvency Due Diligence
IDEXX Laboratories Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.
Score
IDEXX Laboratories Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IDXX Price Targets Summary
IDEXX Laboratories Inc
According to Wall Street analysts, the average 1-year price target for IDXX is 544.69 USD with a low forecast of 409.17 USD and a high forecast of 637.35 USD.
Dividends
Current shareholder yield for IDXX is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
IDXX Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 10,350 full-time employees. The company also offers human medical point-of-care & laboratory diagnostics. Its products include health monitoring, others. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment CAG develops, designs, manufactures, and distributes products and performs services for veterinarians and the biomedical analytics market, primarily related to diagnostics and information management. The Water segment develops, designs, manufactures, and distributes a range of products used in the detection of various microbiological parameters in water. The LPD segment develops, designs, manufactures, and distributes diagnostic tests and related instrumentation and performs services that are used to manage the health status of livestock and poultry.
Officers
The intrinsic value of one IDXX stock under the Base Case scenario is 254.3 USD.
Compared to the current market price of 414.52 USD, IDEXX Laboratories Inc is Overvalued by 39%.